Trial Outcomes & Findings for Effect of Plant Sterols Esterified to Fish Oil Fatty Acids on Plasma Lipid Levels (NCT NCT00441480)
NCT ID: NCT00441480
Last Updated: 2012-01-13
Results Overview
Average of blood test results at -10 and 0 days (before and after run-in period)
COMPLETED
PHASE4
91 participants
at baseline
2012-01-13
Participant Flow
Recruitment period:r May 2007-Jan 2008 (8 months) Medical center
10 -14 days run-in phase during which they received placebo capsules. Run-in phase enabled to exclude subjects who had an unstable weight (gained or lost more than 3 kg) during this period or who didn't meet entry criteria of LDL-c and TG at screening visit and at baseline visit.
Participant milestones
| Measure |
PS-FO
plant sterols esterified to fish oil fatty acids
|
Control
Corn oil
|
|---|---|---|
|
Overall Study
STARTED
|
46
|
45
|
|
Overall Study
COMPLETED
|
43
|
41
|
|
Overall Study
NOT COMPLETED
|
3
|
4
|
Reasons for withdrawal
| Measure |
PS-FO
plant sterols esterified to fish oil fatty acids
|
Control
Corn oil
|
|---|---|---|
|
Overall Study
Protocol Violation
|
1
|
1
|
|
Overall Study
Withdrawal by Subject
|
2
|
3
|
Baseline Characteristics
Effect of Plant Sterols Esterified to Fish Oil Fatty Acids on Plasma Lipid Levels
Baseline characteristics by cohort
| Measure |
PS-FO
n=46 Participants
plant sterols esterified to fish oil fatty acids
|
Control
n=45 Participants
Corn oil
|
Total
n=91 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
41 Participants
n=5 Participants
|
43 Participants
n=7 Participants
|
84 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
5 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
7 Participants
n=5 Participants
|
|
Age Continuous
|
51 years
STANDARD_DEVIATION 10.8 • n=5 Participants
|
49.4 years
STANDARD_DEVIATION 9.3 • n=7 Participants
|
50.2 years
STANDARD_DEVIATION 10.1 • n=5 Participants
|
|
Sex: Female, Male
Female
|
9 Participants
n=5 Participants
|
11 Participants
n=7 Participants
|
20 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
37 Participants
n=5 Participants
|
34 Participants
n=7 Participants
|
71 Participants
n=5 Participants
|
|
Region of Enrollment
Israel
|
46 participants
n=5 Participants
|
45 participants
n=7 Participants
|
91 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: at baselinePopulation: Subjects whose body weight were changed from baseline value by more than 3 kg during the interventions or had compliance below 65% were excluded from analysis before breaking the randomization code. It was done since these changes may have a significant influence on the study end points
Average of blood test results at -10 and 0 days (before and after run-in period)
Outcome measures
| Measure |
PS-FO
n=34 Participants
plant sterols esterified to fish oil fatty acids
|
Control
n=33 Participants
Corn oil
|
|---|---|---|
|
LDL Cholesterol
|
159.7 mg/dl
Standard Deviation 17.22
|
157.8 mg/dl
Standard Deviation 15.54
|
PRIMARY outcome
Timeframe: 12 weeksPopulation: Subjects whose body weight were changed from baseline value by more than 3 kg during the interventions or had compliance below 65% were excluded from analysis before breaking the randomization code. It was done since these changes may have a significant influence on the study end points
Blood test results following 12 weeks of intervention
Outcome measures
| Measure |
PS-FO
n=34 Participants
plant sterols esterified to fish oil fatty acids
|
Control
n=33 Participants
Corn oil
|
|---|---|---|
|
LDL-C
|
154.7 md/dl
Standard Deviation 21.0
|
155.1 md/dl
Standard Deviation 20.1
|
SECONDARY outcome
Timeframe: at baselinePopulation: Subjects whose body weight were changed from baseline value by more than 3 kg during the interventions or had compliance below 65% were excluded from analysis before breaking the randomization code. It was done since these changes may have a significant influence on the study end points
Average of blood test results at -10 and 0 weeks (before and after run-in period)
Outcome measures
| Measure |
PS-FO
n=34 Participants
plant sterols esterified to fish oil fatty acids
|
Control
n=33 Participants
Corn oil
|
|---|---|---|
|
Triglycerides
|
244.9 mg/dl
Standard Deviation 83.2
|
248.9 mg/dl
Standard Deviation 65.4
|
SECONDARY outcome
Timeframe: 12 weeksPopulation: Subjects whose body weight were changed from baseline value by more than 3 kg during the interventions or had compliance below 65% were excluded from analysis before breaking the randomization code. It was done since these changes may have a significant influence on the study end points
Blood test results following 12 weeks of intervention
Outcome measures
| Measure |
PS-FO
n=34 Participants
plant sterols esterified to fish oil fatty acids
|
Control
n=33 Participants
Corn oil
|
|---|---|---|
|
Triglycerides
|
193.9 mg/dl
Standard Deviation 77.0
|
233.0 mg/dl
Standard Deviation 95.0
|
SECONDARY outcome
Timeframe: at baselinePopulation: Subjects whose body weight were changed from baseline value by more than 3 kg during the interventions or had compliance below 65% were excluded from analysis before breaking the randomization code. It was done since these changes may have a significant influence on the study end points
Average of blood test results at -10 and 0 weeks (before and after run-in period)
Outcome measures
| Measure |
PS-FO
n=34 Participants
plant sterols esterified to fish oil fatty acids
|
Control
n=33 Participants
Corn oil
|
|---|---|---|
|
Total Cholesterol
|
244.3 mg/dl
Standard Deviation 24.7
|
239.6 mg/dl
Standard Deviation 22.7
|
SECONDARY outcome
Timeframe: 12 weeksPopulation: Subjects whose body weight were changed from baseline value by more than 3 kg during the interventions or had compliance below 65% were excluded from analysis before breaking the randomization code. It was done since these changes may have a significant influence on the study end points
Blood test results following 12 weeks of intervention
Outcome measures
| Measure |
PS-FO
n=34 Participants
plant sterols esterified to fish oil fatty acids
|
Control
n=33 Participants
Corn oil
|
|---|---|---|
|
Total Cholesterol
|
233.8 mg/dl
Standard Deviation 28.0
|
236.5 mg/dl
Standard Deviation 27.7
|
SECONDARY outcome
Timeframe: at baselinePopulation: Subjects whose body weight were changed from baseline value by more than 3 kg during the interventions or had compliance below 65% were excluded from analysis before breaking the randomization code. It was done since these changes may have a significant influence on the study end points
Average of blood test results at -10 and 0 weeks (before and after run-in period)
Outcome measures
| Measure |
PS-FO
n=34 Participants
plant sterols esterified to fish oil fatty acids
|
Control
n=33 Participants
Corn oil
|
|---|---|---|
|
HDL Cholesterol
|
46.0 mg/dl
Standard Deviation 9.1
|
44.2 mg/dl
Standard Deviation 7.7
|
SECONDARY outcome
Timeframe: 12 weeksPopulation: Subjects whose body weight were changed from baseline value by more than 3 kg during the interventions or had compliance below 65% were excluded from analysis before breaking the randomization code. It was done since these changes may have a significant influence on the study end points
Blood test results following 12 weeks of intervention
Outcome measures
| Measure |
PS-FO
n=34 Participants
plant sterols esterified to fish oil fatty acids
|
Control
n=33 Participants
Corn oil
|
|---|---|---|
|
HDL-cholestrol
|
46.4 mg/dl
Standard Deviation 9.8
|
44.7 mg/dl
Standard Deviation 10.5
|
SECONDARY outcome
Timeframe: at baselinePopulation: Subjects whose body weight were changed from baseline value by more than 3 kg during the interventions or had compliance below 65% were excluded from analysis before breaking the randomization code. It was done since these changes may have a significant influence on the study end points
Blood test results on day 0 of High sensitivity C Reactive Protein
Outcome measures
| Measure |
PS-FO
n=34 Participants
plant sterols esterified to fish oil fatty acids
|
Control
n=33 Participants
Corn oil
|
|---|---|---|
|
CRP
|
3.07 mg/l
Standard Deviation 3.45
|
3.25 mg/l
Standard Deviation 2.61
|
SECONDARY outcome
Timeframe: 12 weeksPopulation: Subjects whose body weight were changed from baseline value by more than 3 kg during the interventions or had compliance below 65% were excluded from analysis before breaking the randomization code. It was done since these changes may have a significant influence on the study end points
Blood test results following 12 weeks of intervention of High sensetivity C reactive protein
Outcome measures
| Measure |
PS-FO
n=34 Participants
plant sterols esterified to fish oil fatty acids
|
Control
n=33 Participants
Corn oil
|
|---|---|---|
|
CRP
|
2.47 mg/l
Standard Deviation 2.45
|
4.51 mg/l
Standard Deviation 4.15
|
SECONDARY outcome
Timeframe: at baselinePopulation: Subjects whose body weight were changed from baseline value by more than 3 kg during the interventions or had compliance below 65% were excluded from analysis before breaking the randomization code. It was done since these changes may have a significant influence on the study end points
Blood test results on day 0
Outcome measures
| Measure |
PS-FO
n=34 Participants
plant sterols esterified to fish oil fatty acids
|
Control
n=33 Participants
Corn oil
|
|---|---|---|
|
Apolipoprotein B100
|
130.6 mg/dl
Standard Deviation 15.7
|
129.4 mg/dl
Standard Deviation 14.3
|
SECONDARY outcome
Timeframe: 12 weeksPopulation: Subjects whose body weight were changed from baseline value by more than 3 kg during the interventions or had compliance below 65% were excluded from analysis before breaking the randomization code. It was done since these changes may have a significant influence on the study end points
Blood test results follwing 12 weeks of intervention
Outcome measures
| Measure |
PS-FO
n=34 Participants
plant sterols esterified to fish oil fatty acids
|
Control
n=33 Participants
Corn oil
|
|---|---|---|
|
Apolipoprotein B100
|
130.0 mg/dl
Standard Deviation 19.1
|
130.3 mg/dl
Standard Deviation 17.0
|
SECONDARY outcome
Timeframe: at baselinePopulation: Subjects whose body weight were changed from baseline value by more than 3 kg during the interventions or had compliance below 65% were excluded from analysis before breaking the randomization code. It was done since these changes may have a significant influence on the study end points
Blood test on day 0
Outcome measures
| Measure |
PS-FO
n=34 Participants
plant sterols esterified to fish oil fatty acids
|
Control
n=33 Participants
Corn oil
|
|---|---|---|
|
Apolipoprotein A
|
126.3 mg/dl
Standard Deviation 13.5
|
125.6 mg/dl
Standard Deviation 13.6
|
SECONDARY outcome
Timeframe: 12 weeksPopulation: Subjects whose body weight were changed from baseline value by more than 3 kg during the interventions or had compliance below 65% were excluded from analysis before breaking the randomization code. It was done since these changes may have a significant influence on the study end points
Blood test results following 12 weeks of intervention
Outcome measures
| Measure |
PS-FO
n=34 Participants
plant sterols esterified to fish oil fatty acids
|
Control
n=33 Participants
Corn oil
|
|---|---|---|
|
Apolipoprotein A
|
128.2 mg/dl
Standard Deviation 14.5
|
127.8 mg/dl
Standard Deviation 16.3
|
Adverse Events
PS-FO
Control
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
PS-FO
n=46 participants at risk
plant sterols esterified to fish oil fatty acids
|
Control
n=45 participants at risk
Corn oil
|
|---|---|---|
|
Gastrointestinal disorders
abdominal discomfort
|
0.00%
0/46
|
2.2%
1/45 • Number of events 1
|
|
Skin and subcutaneous tissue disorders
Itching rash
|
2.2%
1/46 • Number of events 1
|
0.00%
0/45
|
Additional Information
Prof. Dror Harats
The Institute for Lipid and Atherosclerosis Research and Internal Medicine C, Sheba Medical Center, Tel Hashomer
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place